Shares of China Biologic Products gained 24% on Wednesday after the company announced that full-year revenue grew by 155% in 2009.
CBPO stock price closed up $2.18 to $11.26 a share.
China Biologic Products (Nasdaq CBPO) is a biopharmaceutical company that engages in the development and manufacture of plasma-based pharmaceutical products in China.
China Biologic Products also produces antibodies such as Human Rabies Immunoglobulin and Human Hepatitis B Immunoglobulin.
